NCT00012064View on ClinicalTrials.gov

Vaccine Therapy in Treating Patients With Stage IV or Recurrent Melanoma

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

56

Participants

Timeline

Start Date

July 31, 2000

Primary Completion Date

April 30, 2011

Study Completion Date

April 30, 2011

Conditions
Melanoma (Skin)
Interventions
BIOLOGICAL

therapeutic autologous dendritic cells

Apheresis procedure collects peripheral blood mononuclear cells (PBMC) for the production of dendritic cell, which are admixed with irradiated tumor cells from autologous tumor cell line for vaccine product.

Trial Locations (1)

92663

Hoag Cancer Center at Hoag Memorial Hospital Presbyterian, Newport Beach

Sponsors
All Listed Sponsors
lead

Lisata Therapeutics, Inc.

INDUSTRY

NCT00012064 - Vaccine Therapy in Treating Patients With Stage IV or Recurrent Melanoma | Biotech Hunter | Biotech Hunter